Skip to content

JBIO JBIO Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$36.98M+11.9%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$53.01M-34.3%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.7M-49.9%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$50.67M-3.9%
Vor Biopharma logo
Vor BiopharmaVOR
-$220.33M-578%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$105.91M-22.2%

Other financials

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%
CapEx$3.0K
Free cash flow-$33.7M

Valuation

See full
Market cap$1.33B+318%
Enterprise value$1.28B

Returns & leverage

See full
Return on equity-132.5%+120pp
Debt / equity
Current ratio14.3×-17.7×

Where this comes from

Reported directly by JBIO in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is JBIO's comprehensive income (loss), net of tax, attributable to parent?
JBIO (JBIO) reported comprehensive income (loss), net of tax, attributable to parent of -$40.84M in Q1 2026.
How has JBIO's comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
JBIO's comprehensive income (loss), net of tax, attributable to parent decreased by 7.0% year-over-year, from -$38.17M to -$40.84M.
What is the long-term trend for JBIO's comprehensive income (loss), net of tax, attributable to parent?
Over 4 years (2021 to 2025), JBIO's comprehensive income (loss), net of tax, attributable to parent has grown at a 53.3% compound annual growth rate (CAGR), from -$23.02M to -$127.28M.
What does comprehensive income (loss), net of tax, attributable to parent mean?
This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items such as foreign currency adjustments and unrealized gains or losses on securities. It provides a comprehensive view of the company's financial performance beyond traditional net income. Investors use this to assess the total impact of market volatility and accounting adjustments on shareholder value.